Skip to main content

Table 1 Analysis of p53 mutation and IGF2 gene imprinting in human tumor cells

From: Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system

Cell lines

p53 status

IGF2 Imprinting

GES-1

Wild type

MOI

HCT116

Wild type

MOI

HCT8

Wild type

LOI

HT29

Mutation

LOI

  1. LOI: Loss of IGF2 imprinting; MOI: Maintenance of IGF2 imprinting.
Back to article page

Molecular Cancer

ISSN: 1476-4598